Literature DB >> 31964651

The Epidemiology, Virology, and Pathogenicity of Human Infections with Avian Influenza Viruses.

Dayan Wang1, Wenfei Zhu1, Lei Yang1, Yuelong Shu1,2.   

Abstract

Influenza is a global challenge, and future pandemics of influenza are inevitable. One of the lessons learned from past pandemics is that all pandemic influenza viruses characterized to date possess viral genes originating from avian influenza viruses (AIVs). During the past decades, a wide range of AIVs have overcome the species barrier and infected humans with different clinical manifestations ranging from mild illness to severe disease and even death. Understanding the mechanisms of infection in the context of clinical outcomes, the mechanism of interspecies transmission, and the molecular determinants that confer interspecies transmission is important for pandemic preparedness. Here, we summarize the epidemiology, virology, and pathogenicity of human infections with AIVs to further our understanding of interspecies transmission.
Copyright © 2021 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 31964651      PMCID: PMC8015695          DOI: 10.1101/cshperspect.a038620

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  4 in total

1.  Genetic subtyping and phylogenetic analysis of HA and NA from avian influenza virus in wild birds from Peru reveals unique features among circulating strains in America.

Authors:  Gina R Castro-Sanguinetti; Paulo Vitor Marques Simas; Ana Paola Apaza-Chiara; Jose Alonso Callupe-Leyva; Juan Alexander Rondon-Espinoza; Cesar M Gavidia; Juan Anderson More-Bayona; Rosa Isabel Gonzalez Veliz; Vikram N Vakharia; Maria Eliana Icochea
Journal:  PLoS One       Date:  2022-06-07       Impact factor: 3.752

2.  Epidemiologic, Clinical, and Genetic Characteristics of Human Infections with Influenza A(H5N6) Viruses, China.

Authors:  Wenfei Zhu; Xiyan Li; Jie Dong; Hong Bo; Jia Liu; Jiaying Yang; Ye Zhang; Hejiang Wei; Weijuan Huang; Xiang Zhao; Tao Chen; Jing Yang; Zi Li; Xiaoxu Zeng; Chao Li; Jing Tang; Li Xin; Rongbao Gao; Liqi Liu; Min Tan; Yuelong Shu; Lei Yang; Dayan Wang
Journal:  Emerg Infect Dis       Date:  2022-04-27       Impact factor: 16.126

Review 3.  Live attenuated influenza A virus vaccines with modified NS1 proteins for veterinary use.

Authors:  Aitor Nogales; Marta L DeDiego; Luis Martínez-Sobrido
Journal:  Front Cell Infect Microbiol       Date:  2022-07-22       Impact factor: 6.073

4.  Influenza virus repurposes the antiviral protein IFIT2 to promote translation of viral mRNAs.

Authors:  Vy Tran; Mitchell P Ledwith; Thiprampai Thamamongood; Christina A Higgins; Shashank Tripathi; Max W Chang; Christopher Benner; Adolfo García-Sastre; Martin Schwemmle; Adrianus C M Boon; Michael S Diamond; Andrew Mehle
Journal:  Nat Microbiol       Date:  2020-08-24       Impact factor: 17.745

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.